| Financial Year |
March 31 2023 |
| Monetary Funds |
172,976,575.90 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
106,265,755.02 |
| Accounts Receivable |
397,972,291.94 |
| Advances to Suppliers |
12,927,076.23 |
| Other Receivables |
8,943,428.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
969,025.01 |
| Inventories |
300,266,459.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,817,627.20 |
| Total Current Assets |
1,028,583,983.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
19,451,839.40 |
| Investment Properties |
11,962,720.61 |
| Fixed Assetes |
477,665,325.17 |
| Under-construction Projects |
38,194,071.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,372,914.27 |
| R&D expenses |
-- |
| Goodwill |
134,384,459.00 |
| Long-Term Deferred and Prepaid Expenses |
9,023,993.13 |
| Deferred Income Tax Assets |
107,381,122.32 |
| Other Non-Current Assets |
14,709,268.33 |
| Sub-Total of Non-Current Assets |
913,532,868.87 |
| Total Assets |
1,942,116,852.57 |
| Short-Term Loans |
304,812,323.81 |
| Trading Financial liabilities |
-- |
| Notes Payable |
207,061,313.69 |
| Accounts Payable |
307,388,475.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,262,782.73 |
| Taxes Payable |
22,550,963.81 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
103,417,472.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,485,546.17 |
| Other Current Liabilities |
22,421,525.66 |
| Sub-Total of Current Liabilities |
1,007,698,735.21 |
| Long-term Loans |
30,972,820.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,032,799.97 |
| Deferred Income Tax Liabilities |
61,356,494.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
120,778,556.49 |
| Total Liabilities |
1,128,477,291.70 |
| Paid-In Capital(Or Share Stock) |
211,680,000.00 |
| Capital Surplus |
117,656,184.49 |
| Surplus Reserve |
83,705,136.29 |
| LESS:Treasury Stock |
163,092.63 |
| Undistributed Profits |
331,081,606.30 |
| Minority Stockholder's Interest |
71,157,674.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
742,481,886.63 |
| Owner's Equity（Stockholder's Equity） |
813,639,560.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,942,116,852.57 |
